Form 4: AngioDynamics SVP Warren Nighan Jr. Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
Warren Nighan Jr., SVP of Quality and Regulatory at AngioDynamics, disposed of 735 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On July 19, 2024, Warren Nighan Jr., SVP of Quality and Regulatory at AngioDynamics Inc., disposed of 735 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock units granted on July 19, 2023.
- The price per share for the disposition was $7.18.
- Following the transaction, Nighan directly owns 41,526 shares of AngioDynamics Inc.
- The transaction was reported on July 22, 2024.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction to cover tax obligations, and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This transaction is a common occurrence where stock is sold to cover tax obligations related to vesting equity.
Key Dates
| Date | Description |
|---|---|
| 07/19/2023 | Date of grant for restricted stock units that triggered the tax obligation. |
| 07/19/2024 | Date of stock disposal to cover tax obligations. |
| 07/22/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.